COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS

Company Overview - CollPlant Biotechnologies is a regenerative and aesthetics medicine company focused on developing innovative technologies and products based on non-animal-derived rhCollagen for tissue regeneration and medical aesthetics [1][2] - The company specializes in 3D bioprinting of tissues and organs, tissue repair, and medical aesthetics, utilizing proprietary plant-based genetic engineering technology to produce rhCollagen [2] Financial Reporting - CollPlant will report its financial results for the third quarter of 2025 on November 26, 2025, before the opening of U.S. financial markets [1] Strategic Partnerships - In 2021, CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, a subsidiary of AbbVie and a leader in the dermal filler market [3]